Prescription benefit updates Large group

Similar documents
Cigna Drug and Biologic Coverage Policy

2019 Simply Step Therapy Document

Oregon Health Plan prescription benefit updates

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Step Therapy Requirements. Effective: 12/01/2016

Step Therapy Requirements. Effective: 11/01/2018

ALPHA GLUCOSIDASE INHIBITOR THERAPY

Step Therapy Requirements. Effective: 05/01/2018

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

March 2017 Pharmacy & Therapeutics Committee Decisions

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Medications

PPHP 2017 Formulary 2017 Step Therapy Criteria

Formulary Medical Necessity Program

Step Therapy Requirements. Effective: 1/1/2019

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

PharmaSuitables October Rich Price, MD Zach Kareus, Pharm.D. Steve Nolan, Pharm.D.

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Updates to your prescription benefits

2016 Step Therapy (ST) Criteria

ANTICONVULSANTS. Details

ALLERGIC CONJUNCTIVITIS AGENTS

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

HEALTH SHARE/PROVIDENCE (OHP)

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0

Updates to your prescription benefits

STEP THERAPY CRITERIA

FirstCarolinaCare Insurance Company. Step Therapy Requirements

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

Clinical Policy: Roflumilast (Daliresp) Reference Number: CP.PMN.46 Effective Date: Last Review Date: 08.18

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

Part D Pharmacy. An Independent Licensee of the Blue Cross Blue Shield Association ( )

Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes

Step Therapy Requirements

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Insulin Prior Authorization with optional Quantity Limit Program Summary

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

ANTICONVULSANTS. Details

Q&A for Group Administrators: Wellmark Announces Strategic Pharmacy Program Changes to Help Control Drug Spend

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

Overactive bladder (OAB) affects approximately 15% of the adult population. Diagnosis is based

Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018

2015 Step Therapy (ST) Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016

Select Inhaled Respiratory Agents

Pharmacy and Therapeutics Committee Decisions June 17, 2016

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Pharmacy and Therapeutics Committee Decisions March 27, 2015

ANTICONVULSANT STEP THERAPY

12:00 Autonomic Drugs 12:00. Autonomic Drugs

Step Therapy Medications

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

2019 GRS Premier Step Therapy Document

AGGRENOX. Products Affected. Details. Open 1 Last Updated: 10/01/2018. Aggrenox

ANTIDIABETIC AGENTS - MISCELLANEOUS

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

CENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY. Revision Summary or Description

See Important Reminder at the end of this policy for important regulatory and legal information.

Drug Effectiveness Review Project Summary Report Long acting Insulins

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements

F Y 1 9 U T I L I Z A T I O N R E V I E W 7/1/2018 TO 9/30/2018 L O C K T O N C O M P A N I E S

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

2018 Step Therapy Criteria (List of Step Therapy Criteria)

Biologic Immunomodulators Prior Authorization with Quantity Limit Program Summary

8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1)

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol)

Summary of Lothian Joint Formulary Amendments

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

ANTIDIABETIC AGENTS - MISCELLANEOUS

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

STEP THERAPY IN MEDICARE PART D

Transcription:

Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe effective medication treatments. The program also helps you save money on prescription drugs. Periodically, medication coverage changes will occur. These changes allow us to maintain a comprehensive benefit provide you with an open formulary choice, support the program s ongoing stability. Our prescription program uses a tiered copay/coinsurance system. You your doctor can choose between the value, generic, preferred or br tier medications. What you pay for a drug depends on your plan. If your plan does not include a preferred tier, then those medications will be paid at the br tier copay/coinsurance levels. Please review the following expected pharmacy coverage updates. Please note, this information could change does not represent every potential update to your benefits. Refer to your member hbook for specific tier coverage information. Questions? Call our Pharmacy Customer Service team toll-free at 888-361-1610. Value tier Generic tier Preferred tier Br tier Value medications include commonly prescribed medications used to treat chronic medical conditions preserve health. Plans that do not include a value tier benefit will have medications categorized under this tier paid at the generic tier or preferred tier copay/coinsurance levels. Generic medications are considered by physicians pharmacists to be therapeutically the same as br name alternatives at the most favorable cost. Generic medications must contain the same active ingredient as their br name counterparts be identical in strength, dosage format. The preferred tier includes br specialty br name medications that have been reviewed by Moda Health found to be clinically effective at a favorable cost when compared with other medications in the same category. If your plan does not include a preferred tier, then those medications will be paid at the br tier copay/coinsurance level. This tier includes br specialty br name medications that have been reviewed by Moda Health found not to have a significant therapeutic advantage over their preferred tier counterparts. 2016.4 (). For prior effective dates, please contact Moda Health.

Prescription coverage updates These expected Moda Health prescription tier coverage updates go into effect for 2016. Product name Medication class Update Effective Date Additional details Oxybuytnin IR 5mg tablet Add quantity limit on Oxybutynin tablets of 120 tablets per 30 day supply. Oxybuytnin 5mg/ml syrup Add quantity limit on Oxybutynin syrup of 600mL per 30 day supply Detrol 1mg tablet Detrol 2mg tablet (tolterodine IR) Add quantity limit on Detrol of 60 tablets per 30 day supply Detrol LA 2mg capsule Detrol LA 4mg capsule (tolterodine ER) Add quantity limit on Detrol LA of 30 capsules per 30 day supply Trospium IR 20mg tablet Add quantity limit on Trospium IR of 60 tablets per 30 day supply. Trospium ER 60mg capsule Add quantity limit on Trospium ER of 30 capsules per 30 day supply. 2016.4 (). For prior effective dates, please contact Moda Health.

Vesicare 5mg tablet Vesicare 10mg tablet (solifenacin succinate) limit step therapy. Add quantity limit on Vesicare of 30 tablets per 30 day supply. Add step therapy on Vesicare for Toviaz 2mg tablet Toviaz 4mg tablet (fesoterodine fumarate) limit step therapy. Add quantity limit on Toviaz of 30 tablets per 30 day supply. Add step therapy on Toviaz for Enablex 7.5mg tablet Enablex 15mg tablet (darifenacin hydrobromide) limit step therapy. Add quantity limit on Enablex of 30 tablets per 30 day supply. Add step therapy on Enablex for Pradaxa (dabigatran etexilate mesylate) Hematological Add step therapy on Pradaxa for a trial of Xarelto Eliquis. Savaysa (edoxaban tosylate) Hematological Add step therapy on Savaysa for a trial of Xarelto Eliquis. Farxiga (dapagliflozin propanediol) Add step therapy on Farxiga for a trial of generic metformin Invokana, Invokamet, Jardiance or Synjardy. 2016.4 (). For prior effective dates, please contact Moda Health.

Xigduo XR (dapagliflozin/metformin HCl) Add step therapy on Xigduo XR for a trial of generic metformin Invokana, Invokamet, Jardiance or Synjardy. Tresiba (insulin degludec) Add step therapy on Tresiba for a trial of Lantus or Toujeo. Levemir (insulin detemir) Add step therapy on Levemir for a trial of Lantus or Toujeo. Oxytrol (oxybutynin) Add step therapy on Oxytrol for Gelnique (oxybutynin chloride) Add step therapy on Gelnique for Lyrica (pregabalin) Seizure Disorder Add step therapy on Lyrica for trial of generic gabapentin or any of the following: citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, desvenlafaxine, duloxetine, venlafaxine. 2016.4 (). For prior effective dates, please contact Moda Health.

Apidra Apidra Solostar (Insulin Glulisine) a prior Add prior authorization guideline on Apidra Apidra Solostar Afrezza (Insulin Regular, Human) a prior Add prior authorization guideline on Afrezza Oxycontin (Oxycodone Hcl) Pain Management from preferred to nonpreferred. Move Oxycontin from Preferred Br (Tier 2) Humulin N Humulin N Kwikpen (Insulin Nph Human Isophane) Move Humulin N Humulin N Kwikpen from Preferred Br (Tier 2) to Non-Preferred Br (Tier 3) Add prior authorization guideline on Humulin N Humulin N Kwikpen Humulin R (Insulin Regular, Human) Move Humulin R from Preferred Br (Tier 2) Add prior authorization guideline on Humulin R Humulin 70/30 Humulin 70/30 Kwikpen (Insulin Nph Hum/Reg Insulin Hum) Move Humulin 70/30 Humulin 70/30 Kwikpen from Preferred Br (Tier 2) to Non- Preferred Br (Tier 3) Add prior authorization guideline on Humulin 70/30 Kwikpen Humulin 70/30 2016.4 (). For prior effective dates, please contact Moda Health.

Humalog Mix 50/50 Humalog Mix 50/50 Kwikpen (Insulin Lispro Protamin/Lispro) Move Humalog Mix 50/50 Humalog Mix 50/50 Kwikpen from Preferred Br (Tier 2) Add prior authorization guideline on Humalog Mix 50/50 Humalog Mix 50/50 Kwikpen Humalog Mix 75/25 Humalog Mix 75/25 Kwikpen (Insulin Lispro Protamin/Lispro) Move Humalog Mix 75/25 Humalog Mix 75/25 Kwikpen from Preferred Br (Tier 2) Add prior authorization guideline on Humalog Mix 75/25 Humalog Mix 75/25 Kwikpen Humalog Kwikpen U-100 Humalog Kwikpen U-200 (Insulin Lispro) Move Humalog Kwikpen U-100 Humalog Kwikpen U-200 from Preferred Br (Tier 2) Add prior authorization guideline on Humalog Kwikpen U-100 Humalog Kwikpen U-200 Humalog (Insulin Lispro) Move Humalog from Preferred Br (Tier 2) Add prior authorization guideline on Humalog Pancreaze (Lipase/Protease/Amylase) Upper Gastrointestinal Move Pancreaze from Preferred Br (Tier 2) Aubagio (Teriflunomide) Neurological Move Aubagio from Preferred Br (Tier 2) to 2016.4 (). For prior effective dates, please contact Moda Health.

Plegridy (Peginterferon Beta-1a) Neurological Move Plegridy from Preferred Br (Tier 2) to Kineret (Anakinra) Move Kineret from Preferred Br (Tier 2) to Rebif (Interferon Beta- 1a/Albumin) Neurological Move Rebif from Preferred Br (Tier 2) to Cosentyx (Secukinumab) Dermatology - Psoriasis/Eczema Move Cosentyx from Preferred Br (Tier 2) Actemra (Tocilizumab) Move Actemra from Preferred Br (Tier 2) Orencia (Abatacept/Maltose) Move Orencia from Preferred Br (Tier 2) to Xeljanz (Tofacitinib Citrate) Move Xeljanz from Preferred Br (Tier 2) to Cimzia (Certolizumab Pegol) Lower Gastrointestinal Move Cimzia from Preferred Br (Tier 2) to Otezla (Apremilast) Move Otezla from Preferred Br (Tier 2) to 2016.4 (). For prior effective dates, please contact Moda Health.

Simponi (Golimumab) Move Simponi from Preferred Br (Tier 2) to Daraprim (Pyrimethamine) Infectious - Parasitic Move Daraprim from Preferred Br (Tier 2) Tudorza pressair (Aclidinium bromide) Asthma. 4/1/2016 Add step therapy on Tudorza Pressair for a trial of Spiriva or Spiriva Respimat Incruse ellipta (Umeclidinium bromide) Asthma. 4/1/2016 Add step therapy on Incruse Ellipta for a trial of Spiriva or Spiriva Respimat Arcapta neohaler (Indacaterol maleate) Asthma. 4/1/2016 Add step therapy on Arcapta Neohaler for Striverdi Respimat or Serevent Diskus Foradil (Formoterol fumarate) Asthma 4/1/2016 Add step therapy on Foradil for Striverdi Respimat or Serevent Diskus Anoro Ellipta (Umeclidinium bromide/ vilanterol trifenatate powder) Asthma 4/1/2016 Add step therapy on Anoro Ellipta for Stiolto Respimat Epogen (Epoetin alfa) Hematopoietic Agents 1/1/2016 Move Epogen from Specialty Preferred Br (Tier 2) to Specialty Non-Preferred Br (Tier 3) This document is provided for informational purposes only, is intended as a quick reference. For cost further details of the coverage, including exclusions, prior authorization s, any reduction or limitations the terms under which the policy may be continued in force, contact your producer or Moda Health. Copyright 2014 Moda, Inc. All Rights Reserved. Health plans in Washington provided by Moda Health Plan, Inc. Health plans i n California provided by Moda Health Plan, Inc. dba Moda Health Insurance. 2016.4 (). For prior effective dates, please contact Moda Health.